The India
chemotherapy at home service market is anticipated to witness impressive growth
during the forecast period. This can
be ascribed due to the
growing demand for home healthcare service, and even COVID-19 pandemic has
accelerated the demand for home healthcare services in India, as more people
are seeking to avoid hospitals and clinics due to the risk of infection. This
has led to increased interest in chemotherapy at home services, as they provide
a safe and convenient option for cancer patients. Advances in technology have
made it possible to provide high-quality chemotherapy at home services,
including remote monitoring and consultation services. This has improved the
accessibility and quality of care for cancer patients in India. The high cost
of hospital-based treatment is a major concern for many cancer patients and
their families in India. Chemotherapy at home services can be a cost-effective
alternative, as they eliminate the need for hospitalization and reduce the
overall cost of treatment. Cancer being the leading cause of death in India,
the demand for chemotherapy at home services is increasing. The government of
India has launched several initiatives to improve access to healthcare services
in the country, including home healthcare services. Chemotherapy at home allows
patients to receive treatment in the comfort of their own home, without having
to travel to a hospital or clinic. This can be particularly beneficial for
patients who live far away from treatment centers or have mobility issues.
Need For Cost-Effective Healthcare
The high cost of cancer treatment is a significant
burden for many patients and their families in India, and chemotherapy is often
one of the most expensive components of cancer care.
Chemotherapy at home services can be a
cost-effective alternative to hospital-based treatment, as they eliminate the
need for hospitalization and reduce the overall cost of treatment.
Hospitalization can be a major cost driver in cancer care, as it involves
expenses such as room charges, nursing care, and other ancillary services. By
providing chemotherapy at home, healthcare providers can significantly reduce
the cost of treatment and make it more accessible to patients who may not be
able to afford hospital-based care. Also, home-based chemotherapy can reduce
the indirect costs associated with hospitalization, such as lost wages, travel
expenses, and childcare costs. Cost-effective healthcare is a priority for the
government of India and several initiatives are being launched to improve
access to affordable healthcare services in the country. Chemotherapy at home
services provide patients with greater flexibility and convenience. Patients
can receive treatment in the comfort of their own homes, without the need to
travel to a hospital or clinic. This is particularly beneficial for patients
who are elderly or have mobility issues, as well as those who live in rural
areas and have limited access to healthcare facilities. The National Health
Policy 2017, for example, aims to provide universal access to affordable
healthcare services, including home-based care. By providing affordable and
accessible cancer care, chemotherapy at home services can help improve outcomes
for cancer patients and reduce the financial burden of cancer treatment. The
need for cost-effective healthcare is a major driver of the chemotherapy at home
service market in India.
New Technologies
The chemotherapy at home service market in India is
experiencing technological advancements that are helping to improve the quality
and effectiveness of chemotherapy treatment. Some of the new technologies that
are being introduced in the market include mobile applications. Healthcare
providers are using mobile applications to manage chemotherapy treatment plans
for patients as these apps help providers to track patients' treatment
progress, monitor symptoms, and communicate with patients and their caregivers.
Telemedicine is being used to provide remote
consultations and support to patients receiving chemotherapy at home. This
technology enables healthcare providers to monitor patients' health status,
review test results, and adjust treatment plans as needed.
Wearable devices are being used to monitor
patients' vital signs, track their physical activity levels, and monitor medication
adherence. These devices can help healthcare providers to identify potential
problems early on and make timely interventions to prevent complications.
Artificial intelligence (AI) is being used to
analyze patient data and identify patterns that can help predict treatment
outcomes. AI can also be used to identify patients who are at risk of
developing complications and provide early interventions to prevent these
complications from occurring. Remote monitoring systems are being used to
provide real-time monitoring of patients' health status, including vital signs,
and medication adherence. These systems enable healthcare providers to identify
potential problems early on and make timely interventions to prevent complications.
This factor will accelerate the growth of India chemotherapy at home service
market.
Collaborations and Partnerships
Access to expertise and resources, collaborations
and partnerships between service providers, pharmaceutical companies, and other
healthcare organizations can provide access to specialized expertise,
resources, and technology. This can help improve the quality of chemotherapy at
home services and enhance the overall patient experience. Collaborations and
partnerships can help service providers expand their services to new regions or
areas of expertise. For example, partnerships with pharmaceutical companies can
provide access to a wider range of chemotherapy drugs, while collaborations
with other healthcare organizations can help service providers offer
complementary services, such as home nursing care. Collaborations and
partnerships can also help enhance research and development efforts in the
field of chemotherapy at home services. This can lead to the development of new
technologies and treatments, which can improve patient outcomes and help
service providers stay competitive in the market. Collaborations and
partnerships can help service providers increase their brand recognition and
reputation within the healthcare industry. This can lead to increased patient
trust and loyalty, which can help drive growth in the chemotherapy at home
service market.
Download Free Sample Report
Recent Developments
In 2021: HealthCare atHOME (HCAH) India announced a
partnership with Max Super Specialty Hospital in Delhi to provide chemotherapy
at home services to cancer patients.
In 2020: Onco.com announced a partnership with
Medlife, a leading e-pharmacy platform in India, to provide chemotherapy at
home services to cancer patients.
In 2020: HealthCare atHOME (HCAH) India announced a
partnership with Indian Council of Medical Research (ICMR) to conduct clinical
trials for a home-based COVID-19 treatment solution that includes chemotherapy
at home services.
Market Segmentation
India chemotherapy at home service market can be segmented into by product, treatment
stage, cancer type, distribution channel, and region. By product, India chemotherapy at home service
market can be segmented into chemotherapy drugs and chemotherapy infusion
pump. By treatment stage, India chemotherapy at home service market can be segmented into early-stage cancer, advanced-stage cancer,
metastatic cancer, and recurrent cancer. By cancer type, India chemotherapy at home service market
can be segmented into breast cancer, blood cancer, ovarian cancer, colorectal
cancer, and others. By distribution channel, India chemotherapy at home service market can be
segmented into home health agencies, pharmacy-based services, direct-to-patient
services, and others. By Region, India chemotherapy at home service market can be segmented into North India, South India, East India, and West
India.
Market Players
Health Care at Home India Pvt Ltd., PurpleRibbon
Healthcare Services Pvt Ltd., HCG Oncology Healthcare Pvt Ltd, Zoctr Health Pvt
Ltd., and Health Vista Pvt Ltd. (Portea Medical) are some of the market players
in India chemotherapy at home service market.
|
Attribute
|
Details
|
|
Base Year
|
2023
|
|
Historic Data
|
2019 – 2022
|
|
Estimated Year
|
2024
|
|
Forecast Period
|
2025 – 2029
|
|
Quantitative Units
|
Revenue in USD Million and CAGR for 2019-2022 and 2025-2029
|
|
Report Coverage
|
Revenue forecast, company
share, competitive landscape, growth factors, and trends
|
|
Segments Covered
|
Product
Treatment Stage
Cancer Type
Distribution Channel
|
|
Regional Scope
|
North India, South India, East
India, West India
|
|
Key Companies Profiled
|
Health Care at Home India Pvt Ltd., PurpleRibbon Healthcare Services
Pvt Ltd., HCG Oncology Healthcare Pvt Ltd, Zoctr Health Pvt Ltd., Health
Vista Pvt Ltd. (Portea Medical).
|
|
Customization Scope
|
10% free report customization
with purchase. Addition or alteration to country, regional & segment
scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore
purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We
can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, the India chemotherapy at home
service market has been segmented into the following categories, in addition to
the industry trends which have also been detailed below:
- India Chemotherapy at Home Service Market, By Product:
o Chemotherapy Drugs
o Chemotherapy
Infusion Pumps
- India Chemotherapy at Home Service Market, By Treatment
Stage:
o Early-Stage Cancer
o Advanced-Stage Cancer
o Metastatic Cancer
o Recurrent Cancer
- India Chemotherapy at Home Service Market, By Cancer Type:
o Breast Cancer
o Blood Cancer
o Ovarian Cancer
o Colorectal Cancer
- India Chemotherapy at Home
Service Market, By Distribution Channel:
o Home Health Agencies
o Pharmacy-based Services
o Direct-to-Patient Services
- India Chemotherapy at Home Service
Market, By Region:
o
North
India
o
South
India
o
East
India
o
West
India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present India chemotherapy at home service market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India chemotherapy at home service market is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]